To Evaluate the Safety of Duloxetine in Patients With Stress Urinary Incontinence

Lilly

Status and phase: Completed; Phase 3

Conditions: Stress Urinary Incontinence

Treatments: Drug: Duloxetine

Study type: Interventional

Funder types: Industry

Identifiers

NCT00190645

2688

F1J-MC-SBAW

Details and patient eligibility

About

The patients are being followed in this study to determine the safety of taking the medication Duloxetine for a long period of time. The patients participating in this study suffer from Stress Urinary Incontinence.

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Successfully completed the protocol for Study F1J-MC-SBAV.

Exclusion criteria

Treatment with a drug, not including study medication, that has not received regulatory approval at the time of study entry.

Use of excluded medications within 14 days prior to study entry or at any time during the study.

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)